The global blood industry has experienced strong growth from 2005 through 2010 and this is expected to continue through the forecast period. Growth will be fueled by a variety of factors including aging populations in the U.S., Europe and Japan; ongoing technology advancements/new product introductions; and continued strong promotion of blood donation by collection agencies.
Kalorama Information’s Blood: The Worldwide Market for Blood Products, Blood Testing, Blood Equipment, and Synthetic Blood Products of the blood industry provides an analysis of all the key market segments involved in this industry, including products, equipment and testing.
Blood products covered in the report include:
-Red Blood Cells (RBCs)
-Immunoglobulins
-Albumin
-Other Plasma Products
-Synthetic HBOC and PFC Agents
- Recombinant Factors
Blood equipment revenues and forecasts are provided for:
-Blood Collection Equipment
-Automated Blood Collection Equipment
Testing markets covered include:
-Blood Banking and Plasmapheresis Testing
-Blood Typing
-Human Immunodeficiency Virus (HIV) Testing
-Hepatitis A Virus Testing
-Hepatitis B Virus Testing
-Hepatitis C Virus Testing
-Human T-Cell Leukemia Virus Testing
- West Nile Virus Testing
-Other Safety Testing
In addition to complete market data, including forecasts to 2017, the study reports:
-Product demand estimates by region
-Collection and transfusion estimates
-High-blood-loss procedure estimates
-Product pricing
-Reimbursement rates
-Epidemiology of key conditions requiring blood products
-Products on the market and in development
The report also provides discussions of the key trends, as well as the regulatory, business, and clinical challenges facing the various sectors; profiles of 23 major players in the industry are included.
Sales estimates for each market segment represent global revenues and are expressed in current dollars. Estimates are provided for the historic 2005 to 2010 period and forecasts are provided through 2017. Historical information for this report was gathered from a wide variety of published sources including company reports and filings, government documents, legal filings, trade journals, newspapers and business press, analysts’ reports and other sources. Interviews with company representatives were conducted to capture the perspectives from industry participants’ point of view and assess trends, and form the basis of the forecasting and competitive analysis.
CHAPTER ONE: EXECUTIVE SUMMARY
- The Global Blood Industry
- Scope and Methodolgy
- Overview
- Blood Collection
- Blood Typing and Testing for Diseases
- Blood Typing
- Blood Testing
- Blood Storage And Processing
- Blood Transfusions
- Blood Management And Safety Issues
- Synthetic Blood Products
- Blood Products Market
- Blood Testing And Typing Products Market
- Plasma and Blood Collection Equipment Market
- Synthetic Blood Products Market
CHAPTER TWO: OVERVIEW
- The Global Blood Industry
- History of the Blood Industry
- United States
- Europe
- Asia
- Current Blood Industry Issues
- Effects of the Economy
- Changes from Health Care Reform
- Demographic Shifts
- Blood and its Components
- Red Blood Cells (Erythrocytes)
- White Blood Cells (Leukocytes)
- Platelets
- Plasma
- Composition of Blood Plasma
- Immunoglobulin Products
- Blood Transfusions
- Diseases Contracted from Blood Transfusions and Related Identification Testing
- Transfusion-Associated Risks
- Efforts to Create a Virus-Free Blood Supply
- Plasma Treatment
- Platelet Treatment
- Viral Inactivation Methods for Viruses Found in Platelets
- Red Blood Cell Treatments
- Synthetic Blood Products
- Blood Volume Expanders
- Hemoglobin Based Oxygen Carriers
- Perflurocarbon (PFC) Based Blood Products
- Factor Products for Hemophilia A
- Synthetic Platelets
CHAPTER THREE: THE BLOOD MANAGEMENT SYSTEM: BLOOD COLLECTION, PROCESSING AND USE
- Blood Collection
- Organizations Collecting Blood
- Not For-Profit Blood Collection
- Red Cross
- Community Blood Banks
- Hospitals
- Other Blood Collection Sites
- For-Profit Blood Collection
- National Donor Deferral Registry
- Donor Donation Demographics
- Donor Recruitment
- Blood Screening and Evaluation
- Methods for Collecting Blood from Donors
- Manual Blood Collection
- Automated Blood Collection
- Worldwide Annual Blood Collection by Component
- Plasmapheresis
- Red Blood Cell Apheresis
- Cord Blood Collection
- Plasma Collection
- Plasma Fractionators
- Distributors/Brokers
- Blood Typing and Testing for Diseases
- Blood Testing
- Comparison of Direct and Indirect ELISA Tests
- Costs and Other Barriers
- Blood Storage
- Blood Processing
- Cohn Fractionation
- Results of Cohn Fractionation Method
- Newer Fractionation Methods
- Plasma Proteins of Therapeutic Interest
- Advanced Fractionation Methods
- Cascade Plasma Fractionation
- Automated Fractionation
- Blood Transfusions
- Types of Transfusions
- Packed Red Blood Cells
- Platelets
- Leukocytes
- Fresh Frozen Plasma (FFP)
- Cryoprecipi
- Immune Serum Globulin/IMIG/IGIV
- FactorVIII
- Factor IX and Factor IX Complex
- Factor VIIa
- C1 Inhibitor
- Fibrin/Thrombin
- Therapeutic Apheresis
- Blood Management Issues
- Availability
- Safety Issues
- Reducing Blood Typing Errors
- Improving Donor Screening
- Improving Viral Screening
- Increasing Repeat Donation Rates
- Enhancing Viral Inactivation Processes
- Increasing Voluntary Donation
- Preventing Bacterial Infections
- Biovigilence
- Other Safety Precautions
CHAPTER FOUR: THE HUMAN BLOOD AND BLOOD
PRODUCTS MARKET
- Driving Forces of the Human Blood Industry
- Variables Influencing the Demand for Blood Transfusions
- Market Size
- Changing Patterns of Transfusion Procedures
- Leukocyte Reduction
- Types of Autologous Donations
- Pricing of Blood
- National Blood Exchange
- RBCs and Leukoreduced RBCs
- Washed Red Blood Cells
- Deglycerolized Red Blood Cells
- Single-Donor Platelets and Random-Donor Platelets
- Fresh Frozen Plasma and Pooled Frozen Plasma
- Cryoprecipitate
- Granulocytes
- Gamma-Irradiated Blood
- Average Cost of Transfusion
- Plasma and Plasma Derived Products
- Immunoglobulins
- Alpha-1 Proteinase Inhibitors
- Fibrin Sealants
- Clotting Factors and Factor VIIa
CHAPTER FIVE: THE BLOOD TESTING AND TYPING MARKETS
- Blood Testing Products for Donor Screening
- Market Size
vMarket Participants
- Blood Typing Products
- Market Size
- Market Participants
- Plasma and Blood Collection Equipment
- Market Size
- Market Participants
CHAPTER SIX: SYNTHETIC BLOOD PRODUCTS MARKET
- Driving Forces of the Synthetic Blood Products Industry
- Recombinant Factor Market
- Oxygen Carrier Market
- Synthetic Blood Products in Clinical Development
- Hemopure (OPK Biopure)
- Oxygent (Alliance Pharmaceutical)
- Oxycyte (Oxygen Biotherapeutics)
- PHER-O2 (Sanguine)
- Hemospan (Sangart)
- Advate (Baxter)
- Recombinant Factors
- Stem Cell Approaches
- Other Research Initiatives
- Jerome H. Holland Laboratory
- Immune Disease Institute
- National Blood Foundation
CHAPTER SEVEN: TOTAL BLOOD PRODUCTS MARKET
- The Blood Products Industry
- Market Size
CHAPTER EIGHT: COMPANY PROFILES
- AABB
- Abbott Laboratories
- Alliance Pharmaceutical Corp
- America’s Blood Centers
- American Red Cross
- Baxter International
- Bio-Rad Laboratories
- BioTime Inc.
- CSL BEHRING
- Gen-Probe Inc.
- Fenwal
- Grifols Biologicals, Inc.
- JP Laboratories Inc.
- Novartis Diagnostics
- Novo Nordisk A/S
- OPK Biopure
- Perftoran
- Sanguine Corp.
- Oxygen Biotherapeutics
- Talecris Biotherapeutics
Other selected research from the 'Diagnostics' category:
Nosocomial Infections: Market Impact on Diagnostics and Therapeutics: (MRSA, HAP, C. diff and other Hospital Acquired Infections)
Manufacturing and Supply Agreements in Pharma, Biotech and Diagnostics, 2nd edition
Other selected research from the 'Medical Devices' category:
Blood: The Worldwide Market for Blood Products, Blood Testing, Blood Equipment, and Synthetic Blood Products
Mammography Equipment - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016